Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Taipei, T'ai-pei, Taiwan
Founded Date:
2015-01-01
Last Funding Date:
2020-02-26
Total Funding:
$10M
Technology:
diagnostics
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
4
Industry:
Biotechnology, Health Care, Life Science